These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36250250)
1. Right ventricular dysfunction in patients with new-onset heart failure: longitudinal follow-up during guideline-directed medical therapy. Ansari Ramandi MM; van Melle JP; Gorter TM; Hoendermis ES; van Veldhuisen DJ; Nauta JF; van der Wal MHL; Warink-Riemersma J; Voors AA; Dickinson MG Eur J Heart Fail; 2022 Dec; 24(12):2226-2234. PubMed ID: 36250250 [TBL] [Abstract][Full Text] [Related]
2. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518 [TBL] [Abstract][Full Text] [Related]
3. Multiparametric right ventricular assessment improves risk stratification in patients with new-onset acute heart failure. Astengo M; Bobbio E; Polte CL; Täll E; Bollano E; Bech-Hanssen O ESC Heart Fail; 2024 Oct; 11(5):3378-3387. PubMed ID: 38967241 [TBL] [Abstract][Full Text] [Related]
4. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction. Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707 [TBL] [Abstract][Full Text] [Related]
6. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial. Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860 [TBL] [Abstract][Full Text] [Related]
7. Right ventricular free wall and four-chamber longitudinal strain in relation to incident heart failure in the general population. Espersen C; Skaarup KG; Lassen MCH; Johansen ND; Hauser R; Jensen GB; Schnohr P; Møgelvang R; Biering-Sørensen T Eur Heart J Cardiovasc Imaging; 2024 Feb; 25(3):396-403. PubMed ID: 37878747 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension and right ventricular dysfunction in heart failure: prognosis and 15-year prospective longitudinal trajectories in survivors. Santiago-Vacas E; Lupón J; Gavidia-Bovadilla G; Gual-Capllonch F; de Antonio M; Domingo M; Núñez J; Zamora E; Teis A; Moliner P; Codina P; Santesmases J; Bayes-Genis A Eur J Heart Fail; 2020 Jul; 22(7):1214-1225. PubMed ID: 32452102 [TBL] [Abstract][Full Text] [Related]
9. Incidence, Predictive Factors, and Prognostic Impact of Right Ventricular Dysfunction Before Transcatheter Aortic Valve Implantation. Durand E; Sacri C; Levesque T; Tron C; Barbe T; Hemery T; Burdeau J; Dacher JN; Eltchaninoff H Am J Cardiol; 2021 Dec; 161():63-69. PubMed ID: 34794620 [TBL] [Abstract][Full Text] [Related]
10. Right Ventricular Dysfunction and Long-Term Risk of Sudden Cardiac Death in Patients With and Without Severe Left Ventricular Dysfunction. Naksuk N; Tan N; Padmanabhan D; Kancharla K; Makkar N; Yogeswaran V; Gaba P; Kaginele P; Riley DC; Sugrue AM; Rosenbaum AN; El-Harasis MA; Asirvatham SJ; Kapa S; McLeod CJ Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e006091. PubMed ID: 29769224 [TBL] [Abstract][Full Text] [Related]
11. Right ventricular dysfunction in acute heart failure from emergency department to discharge: Predictors and clinical implications. Harrison NE; Ehrman R; Favot M; Gowland L; Lenning J; Abidov A; Henry S; Gupta S; Welch R; Levy P Am J Emerg Med; 2022 Feb; 52():25-33. PubMed ID: 34861517 [TBL] [Abstract][Full Text] [Related]
12. Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction. Dini FL; Carluccio E; Simioniuc A; Biagioli P; Reboldi G; Galeotti GG; Raineri C; Gargani L; Scelsi L; Mandoli GE; Cannito A; Rossi A; Temporelli PL; Ghio S; Eur J Heart Fail; 2016 Dec; 18(12):1462-1471. PubMed ID: 27647757 [TBL] [Abstract][Full Text] [Related]
13. Serum uric acid: A risk factor for right ventricular dysfunction and prognosis in heart failure with preserved ejection fraction. Deng XL; Yi HW; Xiao J; Zhang XF; Zhao J; Sun M; Wen XS; Liu ZQ; Gao L; Li ZY; Ge P; Yu Q; Zhang DY Front Endocrinol (Lausanne); 2023; 14():1143458. PubMed ID: 36950688 [TBL] [Abstract][Full Text] [Related]
14. Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. Aziz EF; Kukin M; Javed F; Musat D; Nader A; Pratap B; Shah A; Enciso JS; Chaudhry FA; Herzog E J Card Fail; 2010 Oct; 16(10):827-34. PubMed ID: 20932465 [TBL] [Abstract][Full Text] [Related]
15. Right ventricular dysfunction in chronic heart failure: clinical laboratory and echocardiographic characteristics. (the RIVED-CHF registry). Palazzuoli A; Dini FL; Agostoni P; Cartocci A; Morrone F; Tricarico L; Correale M; Mercurio V; Nodari S; Severino P; Badagliacca R; Barillà F; Paolillo S; Filardi PP; J Cardiovasc Med (Hagerstown); 2024 Jun; 25(6):457-465. PubMed ID: 38652523 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. Damy T; Kallvikbacka-Bennett A; Goode K; Khaleva O; Lewinter C; Hobkirk J; Nikitin NP; Dubois-Randé JL; Hittinger L; Clark AL; Cleland JG J Card Fail; 2012 Mar; 18(3):216-25. PubMed ID: 22385942 [TBL] [Abstract][Full Text] [Related]
17. Right Heart Dysfunction and Readmission Risk Across Left Ventricular Ejection Fraction Status in Patients With Acute Heart Failure. Santas E; Miñana G; Palau P; Espriella R; Lorenzo M; Núñez G; Sanchis J; Chorro FJ; Bayes-Genís A; Núñez J J Card Fail; 2021 Oct; 27(10):1090-1098. PubMed ID: 34273477 [TBL] [Abstract][Full Text] [Related]
18. Impact of right heart function on outcome in patients with functional mitral regurgitation and chronic heart failure undergoing percutaneous edge-to-edge-repair. Osteresch R; Diehl K; Kühl M; Fiehn E; Schmucker J; Backhaus T; Fach A; Wienbergen H; Hambrecht R J Interv Cardiol; 2018 Dec; 31(6):916-924. PubMed ID: 30397932 [TBL] [Abstract][Full Text] [Related]
19. Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial. Rodés-Cabau J; Lindenfeld J; Abraham WT; Zile MR; Kar S; Bayés-Genís A; Eigler N; Holcomb R; Núñez J; Lee E; Perl ML; Moravsky G; Pfeiffer M; Boehmer J; Gorcsan J; Bax JJ; Anker S; Stone GW Eur J Heart Fail; 2024 Apr; 26(4):1078-1089. PubMed ID: 38561314 [TBL] [Abstract][Full Text] [Related]
20. Impact of β-blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation. Galves R; Da Costa A; Pierrard R; Bayard G; Guichard JB; Isaaz K Echocardiography; 2020 Sep; 37(9):1392-1398. PubMed ID: 32815195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]